The so-called “placebo effect” in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring
- 28 February 1998
- Vol. 51 (2) , 242-250
- https://doi.org/10.1016/s0090-4295(97)00609-2
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Current Status of Thermotherapy of the ProstateJournal of Urology, 1997
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- The hytrin community assessment trial study: A one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasiaUrology, 1996
- A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstructionBritish Journal of Urology, 1994
- The importance of placebo effects in pain treatment and researchPublished by American Medical Association (AMA) ,1994
- Doxazosin Treatment in Patients with Prostatic ObstructionScandinavian Journal of Urology and Nephrology, 1993
- A Randomized, Placebo-Controlled Multicenter Study of the Efficacy and Safety of Terazosin in the Treatment of Benign Prostatic HyperplasiaJournal of Urology, 1992
- The American Urological Association Symptom Index for Benign Prostatic HyperplasiaJournal of Urology, 1992
- The Safety, Efficacy and Compliance of Terazosin Therapy for Benign Prostatic HyperplasiaJournal of Urology, 1992
- Alfuzosin for treatment of benign prostatic hypertrophyThe Lancet, 1991